Systemic sclerosis (SSc) or scleroderma is a rare and complex autoimmune disease. It is clinically classified into two subsets: limited cutaneous (lcSSc) and diffuse cutaneous (dcSSc) SSc. The latter subset is characterized by more rapid progression of skin and visceral involvement, as well as poorer prognosis (1). SSc also can be subgrouped by autoantibody subsets. The most common of these autoantibodies are directed against DNA topoisomerase I (ATA), centromeric proteins (ACA) and RNA polymerases III (anti-RNAP3), as well as other less commonly occurring autoantibodies including U1ribonucleoprotein (anti-UIRNP) (2, 3) .
Specific human leukocyte antigen (HLA) DQB alleles have been associated with SSc. However, major SSc-associated HLA-DQB alleles vary in different ethnic populations. For instance, DQBl *03:01 was associated with susceptibility A total of 213 patients with SSc and 239 gendermatched and unrelated controls were examined for HLA-DQl alleles in the studies. SSc patients were recruited from a multicenter study including hospitals and outpatient clinics in Shanghai, Hebei province, Sichuan province, and Hunan province in China. All patients met the American College of Rheumatology (ACR) classification criteria for SSc (10) , or had at least 3 out of 5 CREST features (Calcinosis, Raynaud's phenomenon, Esophageal dysmotility, Sclerodactyly, and Telangiectasia) with sclerodactyly being mandatory (11) . None of the controls had autoimmune diseases. SSc patients were 91.1% positive for ANA. There were 79 lcSSc and 98 dcSSc, others were undefined. One hundred and ninety patients were examined for ATA with 84 being positive; 163 were examined for ACA with 23 positive; 156 were examined for anti-RNAP3 with 4 positive; 182 were examined for anti-UIRNP with 34 positive. Out of 176 patients who were examined with chest X-ray and/or CT, 134 were diagnosed with positive pulmonary fibrosis. Patients' sera were tested for antinuclear antibodies (ANA) by indirect immunofluorescence using HEp-2 cells as antigen substrate (Antibodies, Davis, CA, USA). ATA and anti-UIRNP were detected by passive immunodiffusion against calf thymus extracts (lNOVA, Diagnostics). ACA was determined by indirect immunofluorescence using HEp-2 cells. Anti-RNAP3 was detected utilizing commercially available kits (NBL, Nagoya, Japan). Genomic DNA was extracted from peripheral blood cells from subjects. The HLA-DQB 1 genotyping was performed with sequence-based typing (SBT) method using SeCore Kits (Life Technologies, USA). The HLA SBT uTYPE 6.0 program (Life Technologies) was used in sequencing analysis and assigning HLA-DQB 1 alleles. Exact p-values were obtained (Fisher's test) from 2x2 tables of allele counts and disease status. The statistical p values less than 0.05 were considered passing normal significance level. Correction for multiple comparisons was performed according to Bonferroni's method. Specifically, a p-value less than 0.00294 was considered significant after adjustment for 17 comparisons.
A total of seventeen DQB 1 alleles were found in the cohort. Frequency of each allele in SSc patients and controls are listed in Table I . HLA-DQB I *03 alleles appeared the most common, especially DQB 1*03:03 in 30.1% of controls vs in 25.6% of SSc patients, and DQBl *03:01 in 23% controls vs in 23.2% SSc patients. In contrast to US Caucasians (4), the difference of allele frequencies of DQBl *03 alleles between Chinese SSc patients and controls appeared not statistically significant. The lack of association between Chinese SSc and DQBI *03:01 was not unexpected. Previous studies of Korean and Japanese SSc also did not report any risk association of DQBI *03:01 with SSc (5, 12) . Genetic heterogeneity among Asian and US populations may significantly impact the complex trait of SSc. DQBl *03:01 appeared to be one of the major DQB I alleles in Han Chinese with 23% frequency in controls, in contrast to in only 16.8% of US Caucasians (4) . It is worth noting that distribution of DQB 1 alleles in the Chinese controls observed in our studies is similar to a previous report of a Chinese population (13) .
On the other hand, DQBl *05:01 was significantly increased in SSc patients (p = 1.6 x l O", 10 .6%
in SSc vs 3.3% in controls in allele frequency, or 20.2% carriers in SSc patients vs 6.7% in controls), and DQB 1*06: II was only observed in SSc patients (1.2%, p = 0.0163) (Table I) . Moreover, comparisons between SSc subsets and controls indicated that the DQBl *05:01 carriers were significantly increased in ACA positive SSc patients, in which 43.5% of patients carry this allele vs only 6.7% of controls (p <10-7 , Odds ratio (OR) = 10.7), A significantly increased DQBl *05:01 also was observed with SSc patients with ATA (21.4%, p = 1.5 X 10-4, OR = 3.8) or pulmonary fibrosis (26.5%, p = 6 X 10-7 , OR = 5.03) and with dcSSc (21.6%, p = 2.1 x 10-S, OR = 3.85).
However, comparisons between SSc subsets and controls may not clearly distinguish the association of the alleles with specific subsets of SSc from the association of the alleles with SSc disease in general. A comparison between subsets with and without a specific phenotype may be better to reveal genetic contribution to specific subsets of SSc. Such comparisons indicated that DQBI *05:01 was persistently associated with ACA positive SSc (Table II) . This association is consistent with the observations in Caucasian, Spanish and Japanese SSc patients (4, 7, 8) . In addition, dcSSc, ATA positive SSc and pulmonary fibrosis of SSc of Han Chinese also demonstrated a higher frequency of DQB I *05:01 (Table II) , which was not reported in other ethnic populations.
In addition, DQBI *06:01 appeared more common in ATA positive Chinese SSc, and was marginally associated with pulmonary fibrosis (Table  II) , which may suggest its potential contribution to severity ofSSc. Of note, an increased DQBl *06:01 frequency was also reported in Japanese SSc (14) . Moreover, an increased frequency of DQB 1*03:03 was observed in anti-U1 RNP positive SSc patients, which was unique in this Han Chinese population, although the association was not persistent after Bonferroni's correction. These observations may need to be confirmed in a large sample size of SSc cohort and/or other ethnic populations.
Two previously reported SSc-protective alleles DQBl *02:02 and *06:02 in US Caucasians (4) did not show association with Chinese SSc, in which the former displayed a normal frequency, and the latter was slightly decreased. However, it appeared inconsistent with SSc of US Hispanics and African-Americans (4).
In summary, this is the first report of studies of HLA-DQB in Chinese SSc. It revealed different genetic aspects ofSSc. The distribution ofHLA-DQB I alleles in Chinese SSc appeared largely different from other ethnic populations, especially Caucasians, Hispanics and Afro-Americans, which implicates ethnic differences in genetic association of SSc. On the other hand, significantly increased DQBI *05:01 in Chinese SSc patients also is a common risk allele to ACA positive SSc in several ethnic populations. Therefore, different ethnic populations also share some genetic determinants of SSc.
